|
HY-101559-50ug
|
MedChemexpress LLC
|
10-Nitrooleic acid [CAS 875685-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101559S-100ug
|
MedChemexpress LLC
|
10-Nitrooleate-d17 (nitrate) [CAS 2749984-40-3]
|
|
|
|
|
HY-10294-10mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10294-25mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10294-5mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103243-10mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-100mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-25mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-5mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-50mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10569-10mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-100mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-5mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-50mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10656-10mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10656-100mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10656-25mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10656-5mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10656-50mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106688A-5mg
|
MedChemexpress LLC
|
Alinidine (hydrobromide) [CAS 71306-36-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107346-100mg
|
MedChemexpress LLC
|
Enbucrilate [CAS 6606-65-1]
|
|
|
|
|
HY-107408-10mg
|
MedChemexpress LLC
|
SANT 2 [CAS 329196-48-7]
|
|
Cancer-programmed cell death
|
|
|
HY-107408-25mg
|
MedChemexpress LLC
|
SANT 2 [CAS 329196-48-7]
|
|
Cancer-programmed cell death
|
|
|
HY-107408-5mg
|
MedChemexpress LLC
|
SANT 2 [CAS 329196-48-7]
|
|
Cancer-programmed cell death
|
|
|
HY-107408-50mg
|
MedChemexpress LLC
|
SANT 2 [CAS 329196-48-7]
|
|
Cancer-programmed cell death
|
|
